{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T14:59:04Z","timestamp":1794322744316,"version":"4.9.0"},"reference-count":230,"publisher":"Informa UK Limited","issue":"11","license":[{"start":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T00:00:00Z","timestamp":1631750400000},"content-version":"unspecified","delay-in-days":54,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"manuscript was not"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2021,7,24]]},"DOI":"10.1080\/14656566.2021.1904891","type":"journal-article","created":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T00:31:10Z","timestamp":1617755470000},"page":"1455-1474","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":61,"title":["Escalating antimicrobial resistance among Enterobacteriaceae: focus on carbapenemases"],"prefix":"10.1080","volume":"22","author":[{"suffix":"III","given":"Joseph P.","family":"Lynch","sequence":"first","affiliation":[{"name":"The David Geffen School of Medicine at UCLA","place":["Los Angeles, CA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5670-4443","authenticated-orcid":false,"given":"Nina M.","family":"Clark","sequence":"additional","affiliation":[{"name":"Loyola University Chicago","place":["Maywood"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George G.","family":"Zhanel","sequence":"additional","affiliation":[{"name":"University of Manitoba","place":["Winnipeg, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,8,16]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid1710.110655"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.3109\/1040841X.2012.691870"},{"issue":"2","key":"e_1_3_4_5_1","first-page":"108","article-title":"Clinical and economic burden of community-acquired pneumonia amongst adults in the Asia-Pacific region","volume":"38","author":"Song J-H","year":"2011","unstructured":"Song J-H, Thamlikitkul V, Hsueh P-R. Clinical and economic burden of community-acquired pneumonia amongst adults in the Asia-Pacific region. Int J Antimicrob Agents. 2011;38(2):108\u2013117.","journal-title":"Int J Antimicrob Agents"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkp255"},{"key":"e_1_3_4_7_1","first-page":"9(10):693","article-title":"Molecular epidemiology of Carbapenemases in Enterobacteriales from humans, animals, food and the environment","author":"Taggar G","year":"2020","unstructured":"Taggar G, Attiq Rheman M, Boerlin P, et al. Molecular epidemiology of Carbapenemases in Enterobacteriales from humans, animals, food and the environment. Antibiotics (Basel). 2020;9(10):693.","journal-title":"Antibiotics (Basel)"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1868"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2016.09.003"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h6420"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2013.763030"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1295"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid2007.121004"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw282"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-micro-090110-102911"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl483"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1086\/588004"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e31822827e0"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks300"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1086\/588048"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid2611.202203"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2009.02941.x"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1086\/604713"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01338-09"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkq415"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2011.06.001"},{"key":"e_1_3_4_27_1","first-page":"33(1):e00102-19","article-title":"The Global Ascendency of OXA-48-Type Carbapenemases","author":"Pitout JDD","year":"2019","unstructured":"Pitout JDD, Peirano G, Kock MM, et al. The Global Ascendency of OXA-48-Type Carbapenemases. Clin Microbiol Rev. 2019;33(1):e00102-19.","journal-title":"Clin Microbiol Rev"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid1402.070350"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-6976.2011.00268.x"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01009-09"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1086\/420816"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2012.03821.x"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.3390\/medsci6010001"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.4.824"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00774-09"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268819000256"},{"key":"e_1_3_4_37_1","first-page":"32(2);e00115-18","article-title":"NDM Metallo-beta-Lactamases and their bacterial producers in health care settings","author":"Wu W","year":"2019","unstructured":"Wu W, Feng Y, Tang G, et al. NDM Metallo-beta-Lactamases and their bacterial producers in health care settings. Clin Microbiol Rev. 2019;32(2);e00115-18.","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"e_1_3_4_38_1","first-page":"e00305","article-title":"Meropenem-Vaborbactam activity against Carbapenem-Resistant Enterobacterales isolates collected in U.S. hospitals during 2016 to 2018","volume":"64","author":"Castanheira M","year":"2020","unstructured":"Castanheira M, Doyle TB, Kantro V, et al. Meropenem-Vaborbactam activity against Carbapenem-Resistant Enterobacterales isolates collected in U.S. hospitals during 2016 to 2018. Antimicrob Agents Chemother. 2020;64(4):e00305\u201320.","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1089\/mdr.2018.0080"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2006.01480.x"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(10)70276-0"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid1701.101331"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(10)70143-2"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1011715"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr337"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2012.03928.x"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr256"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2011.03726.x"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkq273"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr082"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2020.25.6.2000085"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S236766"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkq108"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.4.1151-1161.2001"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00126-09"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks063"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00089-09"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkp018"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00299-07"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.05956-11"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.05576-11"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid1808.110893"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2011.01.009"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00284-020-02242-6"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.02007"},{"key":"e_1_3_4_66_1","first-page":"5(5):e00756-20","article-title":"Clinical and molecular description of a high-copy IncQ1 KPC-2 plasmid harbored by the international ST15 Klebsiella pneumoniae clone","author":"Martins W","year":"2020","unstructured":"Martins W, Nicolas MF, Yu Y, et al. Clinical and molecular description of a high-copy IncQ1 KPC-2 plasmid harbored by the international ST15 Klebsiella pneumoniae clone. mSphere. 2020;5(5):e00756-20.","journal-title":"mSphere"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1590\/0037-8682-0397-2020"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/871947"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.26633\/RPSP.2020.50"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjid.2020.03.002"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-016-1927-y"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkp207"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02166-13"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00459-12"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-015-0597-z"},{"key":"e_1_3_4_76_1","first-page":"24(5):1800159","article-title":"Bloodstream infections due to carbapenemase-producing Enterobacteriaceae in Italy: results from nationwide surveillance, 2014 to 2017","author":"Iacchini S","year":"2019","unstructured":"Iacchini S, Sabbatucci M, Gagliotti C, et al. Bloodstream infections due to carbapenemase-producing Enterobacteriaceae in Italy: results from nationwide surveillance, 2014 to 2017. Euro Surveill. 2019;24(5):1800159.","journal-title":"Euro Surveill"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-4268-9"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2017.06.003"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(09)70054-4"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.1.15-22.2004"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01312-09"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01452-10"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr023"},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr396"},{"key":"e_1_3_4_85_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01497-10"},{"key":"e_1_3_4_86_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid1809.111727"},{"key":"e_1_3_4_87_1","doi-asserted-by":"publisher","DOI":"10.1089\/mdr.2020.0265"},{"key":"e_1_3_4_88_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.02068"},{"key":"e_1_3_4_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2020.104507"},{"key":"e_1_3_4_90_1","first-page":"63(7):e00517-19","article-title":"Two Hypervirulent Klebsiella pneumoniae Isolates Producing a bla KPC-2 Carbapenemase from a Canadian patient","author":"Mataseje LF","year":"2019","unstructured":"Mataseje LF, Boyd DA, Mulvey MR, et al. Two Hypervirulent Klebsiella pneumoniae Isolates Producing a bla KPC-2 Carbapenemase from a Canadian patient. Antimicrob Agents Chemother. 2019;63(7):e00517-19.","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_3_4_91_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkz125"},{"key":"e_1_3_4_92_1","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/taz036"},{"key":"e_1_3_4_93_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00162-14"},{"key":"e_1_3_4_94_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01359-16"},{"key":"e_1_3_4_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2020.06.017"},{"key":"e_1_3_4_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psj.2020.08.050"},{"key":"e_1_3_4_97_1","doi-asserted-by":"publisher","DOI":"10.1099\/acmi.0.000125"},{"key":"e_1_3_4_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mimet.2020.106070"},{"key":"e_1_3_4_99_1","first-page":"8","article-title":"High colonization rate and heterogeneity of ESBL- and Carbapenemase-Producing Enterobacteriaceae Isolated from Gull Feces in Lisbon, Portugal","author":"Aires-de-sousa M","year":"2020","unstructured":"Aires-de-sousa M, Fournier C, Lopes E, et al. High colonization rate and heterogeneity of ESBL- and Carbapenemase-Producing Enterobacteriaceae Isolated from Gull Feces in Lisbon, Portugal. Microorganisms. 2020;8.","journal-title":"Microorganisms"},{"key":"e_1_3_4_100_1","doi-asserted-by":"publisher","DOI":"10.1080\/1040841X.2020.1812510"},{"key":"e_1_3_4_101_1","first-page":"8(10):1593","article-title":"First Detection of GES-5-Producing Escherichia coli from Livestock-An Increasing Diversity of Carbapenemases recognized from German Pig Production","author":"Irrgang A","year":"2020","unstructured":"Irrgang A, Tausch SH, Pauly N, et al. First Detection of GES-5-Producing Escherichia coli from Livestock-An Increasing Diversity of Carbapenemases recognized from German Pig Production. Microorganisms. 2020;8(10):1593.","journal-title":"Microorganisms"},{"key":"e_1_3_4_102_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-020-09591-8"},{"key":"e_1_3_4_103_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1717295115"},{"issue":"6","key":"e_1_3_4_104_1","first-page":"vi3","article-title":"European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe (1997-2009)","volume":"66","author":"Adriaenssens N","year":"2011","unstructured":"Adriaenssens N, Coenen S, Versporten A, et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe (1997-2009). J Antimicrob Chemother. 2011;66(Suppl 6):vi3\u201312.","journal-title":"J Antimicrob Chemother"},{"key":"e_1_3_4_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2020.04.002"},{"key":"e_1_3_4_106_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3182804b49"},{"key":"e_1_3_4_107_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.12480"},{"key":"e_1_3_4_108_1","doi-asserted-by":"publisher","DOI":"10.1086\/664055"},{"key":"e_1_3_4_109_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis036"},{"key":"e_1_3_4_110_1","first-page":"62(2):e01882-17","article-title":"Epidemiology of Carbapenem-Resistant Enterobacteriaceae infections: report from the China CRE network","author":"Zhang Y","year":"2018","unstructured":"Zhang Y, Wang Q, Yin Y, et al. Epidemiology of Carbapenem-Resistant Enterobacteriaceae infections: report from the China CRE network. Antimicrob Agents Chemother. 2018;62(2):e01882-17.","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_3_4_111_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2297-9"},{"key":"e_1_3_4_112_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.01422"},{"key":"e_1_3_4_113_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12941-017-0191-3"},{"key":"e_1_3_4_114_1","article-title":"Predictors of mortality and clinical characteristics among carbapenem-resistant or carbapenemase-producing Enterobacteriaceae bloodstream infections in Spanish children","author":"Ara-Montojo MF","year":"2020","unstructured":"Ara-Montojo MF, Escosa-Garcia L, Alguacil-Guillen M, et al. Predictors of mortality and clinical characteristics among carbapenem-resistant or carbapenemase-producing Enterobacteriaceae bloodstream infections in Spanish children. J Antimicrob Chemother. 2020;76(1):220-225.","journal-title":"J Antimicrob Chemother"},{"key":"e_1_3_4_115_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2011.05.022"},{"key":"e_1_3_4_116_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix113"},{"key":"e_1_3_4_117_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24489"},{"key":"e_1_3_4_118_1","doi-asserted-by":"publisher","DOI":"10.1080\/1120009X.2019.1685794"},{"key":"e_1_3_4_119_1","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-017-1063-7"},{"key":"e_1_3_4_120_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2012.03888.x"},{"key":"e_1_3_4_121_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2016.12.013"},{"key":"e_1_3_4_122_1","first-page":"17(19):6943","article-title":"Characteristics of microbial factors of healthcare-associated infections including multidrug-resistant pathogens and antibiotic consumption at the university intensive care unit in Poland in the Years 2011-2018","author":"Litwin A","year":"2020","unstructured":"Litwin A, Fedorowicz O, Duszynska W. Characteristics of microbial factors of healthcare-associated infections including multidrug-resistant pathogens and antibiotic consumption at the university intensive care unit in Poland in the Years 2011-2018. Int J Environ Res Public Health. 2020;17(19):6943.","journal-title":"Int J Environ Res Public Health"},{"key":"e_1_3_4_123_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02373-13"},{"key":"e_1_3_4_124_1","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12747"},{"key":"e_1_3_4_125_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix991"},{"key":"e_1_3_4_126_1","doi-asserted-by":"publisher","DOI":"10.1086\/659762"},{"key":"e_1_3_4_127_1","first-page":"23(8):17-00078","article-title":"Efficiency of different control measures for preventing carbapenemase-producing enterobacteria and glycopeptide-resistant Enterococcus faecium outbreaks: a 6-year prospective study in a French multihospital institution, January 2010 to December 2015","author":"Fournier S","year":"2018","unstructured":"Fournier S, Desenfant L, Monteil C, et al. Efficiency of different control measures for preventing carbapenemase-producing enterobacteria and glycopeptide-resistant Enterococcus faecium outbreaks: a 6-year prospective study in a French multihospital institution, January 2010 to December 2015. Euro Surveill. 2018;23(8):17-00078.","journal-title":"Euro Surveill"},{"key":"e_1_3_4_128_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.2717"},{"key":"e_1_3_4_129_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02289-15"},{"key":"e_1_3_4_130_1","doi-asserted-by":"publisher","DOI":"10.14745\/ccdr.v46i05a01"},{"key":"e_1_3_4_131_1","first-page":"62(8):e00266-18","article-title":"Diversity of Carbapenemase-producing Escherichia coli isolates in France in 2012-2013","author":"Gauthier L","year":"2018","unstructured":"Gauthier L, Dortet L, Cotellon G, et al. Diversity of Carbapenemase-producing Escherichia coli isolates in France in 2012-2013. Antimicrob Agents Chemother. 2018;62(8):e00266-18.","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_3_4_132_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2015.20.45.30062"},{"key":"e_1_3_4_133_1","first-page":"24(9):1900123","article-title":"Worsening epidemiological situation of carbapenemase-producing Enterobacteriaceae in Europe, assessment by national experts from 37 countries, July 2018","author":"Brolund A","year":"2019","unstructured":"Brolund A, Lagerqvist N, Byfors S, et al. Worsening epidemiological situation of carbapenemase-producing Enterobacteriaceae in Europe, assessment by national experts from 37 countries, July 2018. Euro Surveill. 2019;24(9):1900123.","journal-title":"Euro Surveill"},{"key":"e_1_3_4_134_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2017.08.019"},{"key":"e_1_3_4_135_1","first-page":"25(48):2001779","article-title":"Extremely drug-resistant NDM-9-producing ST147 Klebsiella pneumoniae causing infections in Italy, May 2020","author":"Falcone M","year":"2020","unstructured":"Falcone M, Giordano C, Barnini S, et al. Extremely drug-resistant NDM-9-producing ST147 Klebsiella pneumoniae causing infections in Italy, May 2020. Euro Surveill. 2020;25(48):2001779.","journal-title":"Euro Surveill"},{"key":"e_1_3_4_136_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.medmal.2020.01.011"},{"key":"e_1_3_4_137_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy660"},{"key":"e_1_3_4_138_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-020-00757-y"},{"key":"e_1_3_4_139_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2018.05.019"},{"key":"e_1_3_4_140_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmni.2020.100727"},{"key":"e_1_3_4_141_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dku356"},{"key":"e_1_3_4_142_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-016-1858-7"},{"key":"e_1_3_4_143_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2018.02.007"},{"key":"e_1_3_4_144_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2019.11.014"},{"key":"e_1_3_4_145_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2017.08.030"},{"key":"e_1_3_4_146_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ003"},{"key":"e_1_3_4_147_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.566060"},{"key":"e_1_3_4_148_1","doi-asserted-by":"publisher","DOI":"10.1177\/2049936120912049"},{"key":"e_1_3_4_149_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis588"},{"key":"e_1_3_4_150_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.06268-11"},{"key":"e_1_3_4_151_1","first-page":"62(6):e02562-17","article-title":"Comparison of septic shock due to Multidrug-Resistant Acinetobacter baumannii or Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae in intensive care unit patients","author":"Russo A","year":"2018","unstructured":"Russo A, Giuliano S, Ceccarelli G, et al. Comparison of septic shock due to Multidrug-Resistant Acinetobacter baumannii or Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae in intensive care unit patients. Antimicrob Agents Chemother. 2018;62(6):e02562-17.","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_3_4_152_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz194"},{"key":"e_1_3_4_153_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2016.10.002"},{"key":"e_1_3_4_154_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-017-2936-5"},{"key":"e_1_3_4_155_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02399-12"},{"key":"e_1_3_4_156_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01569-15"},{"key":"e_1_3_4_157_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01420-10"},{"key":"e_1_3_4_158_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2016.11.026"},{"key":"e_1_3_4_159_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2017.04.011"},{"key":"e_1_3_4_160_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2011.03514.x"},{"key":"e_1_3_4_161_1","doi-asserted-by":"publisher","DOI":"10.1086\/592412"},{"key":"e_1_3_4_162_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2016.01.016"},{"key":"e_1_3_4_163_1","doi-asserted-by":"publisher","DOI":"10.1086\/518605"},{"key":"e_1_3_4_164_1","doi-asserted-by":"publisher","DOI":"10.1586\/eri.12.25"},{"key":"e_1_3_4_165_1","doi-asserted-by":"publisher","DOI":"10.1177\/2049936120952604"},{"key":"e_1_3_4_166_1","first-page":"63(1):e01832-18","article-title":"In Vitro Activity of Plazomicin against Gram-Negative and Gram-Positive Bacterial Pathogens Isolated from Patients in Canadian Hospitals from 2013 to 2017 as Part of the CANWARD Surveillance Study","author":"Walkty A","year":"2019","unstructured":"Walkty A, Karlowsky JA, Baxter MR, et al. In Vitro Activity of Plazomicin against Gram-Negative and Gram-Positive Bacterial Pathogens Isolated from Patients in Canadian Hospitals from 2013 to 2017 as Part of the CANWARD Surveillance Study. Antimicrob Agents Chemother. 2019;63(1):e01832-18.","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_3_4_167_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1801467"},{"issue":"12","key":"e_1_3_4_168_1","first-page":"3346","article-title":"Activity of plazomicin compared with other aminoglycosides against isolates from European and adjacent countries, including Enterobacteriaceae molecularly characterized for aminoglycoside-modifying enzymes and other resistance mechanisms","volume":"73","author":"Castanheira M","year":"2018","unstructured":"Castanheira M, Deshpande LM, Woosley LN, et al. Activity of plazomicin compared with other aminoglycosides against isolates from European and adjacent countries, including Enterobacteriaceae molecularly characterized for aminoglycoside-modifying enzymes and other resistance mechanisms. J Antimicrob Chemother. 2018;73(12):3346\u20133354.","journal-title":"J Antimicrob Chemother"},{"key":"e_1_3_4_169_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1807634"},{"key":"e_1_3_4_170_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkz283"},{"key":"e_1_3_4_171_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2020.115239"},{"key":"e_1_3_4_172_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2209"},{"key":"e_1_3_4_173_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.03.007"},{"key":"e_1_3_4_174_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2014.07.010"},{"key":"e_1_3_4_175_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30099-9"},{"key":"e_1_3_4_176_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy371"},{"issue":"11","key":"e_1_3_4_177_1","first-page":"8","article-title":"Colistin update on its mechanism of action and resistance, present and future challenges","author":"Andrade FF","year":"2020","unstructured":"Andrade FF, Silva D, Rodrigues A, et al. Colistin update on its mechanism of action and resistance, present and future challenges. Microorganisms. 2020;8(11):1716.\u00a0DOI:10.3390","journal-title":"Microorganisms"},{"key":"e_1_3_4_178_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2020.07.025"},{"key":"e_1_3_4_179_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl441"},{"key":"e_1_3_4_180_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2010.05.012"},{"key":"e_1_3_4_181_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000000933"},{"key":"e_1_3_4_182_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-016-0545-8"},{"key":"e_1_3_4_183_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2017.12.013"},{"key":"e_1_3_4_184_1","first-page":"56(6):106178","article-title":"In-vitro activity of Eravacycline compared to Tigecycline and Carbapenem-resistant Enterobacteriaceae","author":"Clark JA","year":"2020","unstructured":"Clark JA, Kulengowski B, Burgess DS. In-vitro activity of Eravacycline compared to Tigecycline and Carbapenem-resistant Enterobacteriaceae. Int J Antimicrob Agents. 2020;56(6):106178.","journal-title":"Int J Antimicrob Agents"},{"key":"e_1_3_4_185_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-4093-1"},{"key":"e_1_3_4_186_1","first-page":"64(3):e01699-19","article-title":"In vitro activity of Eravacycline against Gram-Negative Bacilli Isolated in Clinical Laboratories Worldwide from 2013 to 2017","author":"Morrissey I","year":"2020","unstructured":"Morrissey I, Olesky M, Hawser S, et al. In vitro activity of Eravacycline against Gram-Negative Bacilli Isolated in Clinical Laboratories Worldwide from 2013 to 2017. Antimicrob Agents Chemother. 2020;22(5):556-561;64(3):e01699-19.","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_3_4_187_1","doi-asserted-by":"publisher","DOI":"10.1089\/sur.2020.241"},{"key":"e_1_3_4_188_1","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8912039"},{"key":"e_1_3_4_189_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2020.09.022"},{"key":"e_1_3_4_190_1","first-page":"9(9):615","article-title":"Evaluation of Intravenous Fosfomycin Disodium Dosing Regimens in Critically Ill Patients for Treatment of Carbapenem-Resistant Enterobacterales Infections Using Monte Carlo Simulation","author":"Leelawattanachai P","year":"2020","unstructured":"Leelawattanachai P, Wattanavijitkul T, Paiboonvong T, et al. Evaluation of Intravenous Fosfomycin Disodium Dosing Regimens in Critically Ill Patients for Treatment of Carbapenem-Resistant Enterobacterales Infections Using Monte Carlo Simulation. Antibiotics (Basel). 2020;9(9):615.","journal-title":"Antibiotics (Basel)"},{"key":"e_1_3_4_191_1","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-019-01323-4"},{"key":"e_1_3_4_192_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(09)70325-1"},{"key":"e_1_3_4_193_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00634-19"},{"key":"e_1_3_4_194_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.medmal.2020.07.003"},{"key":"e_1_3_4_195_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks319"},{"key":"e_1_3_4_196_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks270"},{"key":"e_1_3_4_197_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.04.034"},{"key":"e_1_3_4_198_1","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0000000000000490"},{"key":"e_1_3_4_199_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-013-0013-7"},{"key":"e_1_3_4_200_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw636"},{"key":"e_1_3_4_201_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1205073109"},{"key":"e_1_3_4_202_1","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0000000000000433"},{"key":"e_1_3_4_203_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.00080"},{"key":"e_1_3_4_204_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy576"},{"key":"e_1_3_4_205_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy492"},{"key":"e_1_3_4_206_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02243-16"},{"key":"e_1_3_4_207_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx496"},{"key":"e_1_3_4_208_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz1155"},{"key":"e_1_3_4_209_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-017-0851-9"},{"key":"e_1_3_4_210_1","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.001142"},{"key":"e_1_3_4_211_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2019.10.028"},{"key":"e_1_3_4_212_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz530"},{"key":"e_1_3_4_213_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-020-00344-z"},{"key":"e_1_3_4_214_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2018.02.021"},{"key":"e_1_3_4_215_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2020.01.023"},{"key":"e_1_3_4_216_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-020-00350-1"},{"key":"e_1_3_4_217_1","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S150447"},{"key":"e_1_3_4_218_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-018-0214-1"},{"issue":"5","key":"e_1_3_4_219_1","first-page":"e02313","article-title":"Meropenem-Vaborbactam versus Ceftazidime-Avibactam for Treatment of Carbapenem-Resistant Enterobacteriaceae infections","author":"Ackley R","year":"2020","unstructured":"Ackley R, Roshdy D, Meredith J, et al. Meropenem-Vaborbactam versus Ceftazidime-Avibactam for Treatment of Carbapenem-Resistant Enterobacteriaceae infections. Antimicrob Agents Chemother. 2020.(5):e02313\u201319.","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_3_4_220_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01551-18"},{"key":"e_1_3_4_221_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01936-19"},{"key":"e_1_3_4_222_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa051"},{"key":"e_1_3_4_223_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11908-020-0716-3"},{"key":"e_1_3_4_224_1","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2020.1840552"},{"key":"e_1_3_4_225_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-013-0168-2"},{"key":"e_1_3_4_226_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-019-1055-2"},{"key":"e_1_3_4_227_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2476"},{"key":"e_1_3_4_228_1","first-page":"62","article-title":"In Vitro Activity of the Siderophore Cephalosporin, Cefiderocol, against Carbapenem-Nonsusceptible and Multidrug-Resistant Isolates of Gram-Negative Bacilli Collected Worldwide in 2014 to 2016","author":"Hackel MA","year":"2018","unstructured":"Hackel MA, Tsuji M, Yamano Y, et al. In Vitro Activity of the Siderophore Cephalosporin, Cefiderocol, against Carbapenem-Nonsusceptible and Multidrug-Resistant Isolates of Gram-Negative Bacilli Collected Worldwide in 2014 to 2016. Antimicrob Agents Chemother. 2018;62:e0196817.","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_3_4_229_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2020.10.008"},{"key":"e_1_3_4_230_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1410"},{"key":"e_1_3_4_231_1","article-title":"Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial","author":"Bassetti M","year":"2020","unstructured":"Bassetti M, Echols R, Matsunaga Y, et al. Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial. Lancet Infect Dis. 2020;21(2);226-240.","journal-title":"Lancet Infect Dis"},{"key":"e_1_3_4_232_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30731-3"}],"updated-by":[{"DOI":"10.1080\/14656566.2021.1981568","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T00:00:00Z","timestamp":1632787200000}}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2021.1904891","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T11:47:38Z","timestamp":1770378458000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2021.1904891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,24]]},"references-count":230,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,7,24]]}},"alternative-id":["10.1080\/14656566.2021.1904891"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2021.1904891","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,24]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-12-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}